Skip to main content

Advertisement

Log in

Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to compare whole-lesion (WL) enhancement parameters to single region of interest (ROI)-based enhancement in discriminating clear cell renal cell carcinoma (ccRCC) from renal oncocytoma.

Materials and Methods

In this IRB-approved retrospective study, the surgical database was queried to derive a cohort of 94 postnephrectomy patients with ccRCC or oncocytoma (68 ccRCC, 26 oncocytoma), who underwent preoperative multiphase contrast-enhanced computed tomography (CECT) between June 2009 and August 2013. CT acquisitions were transferred to a three-dimensional workstation, and WL ROIs were manually segmented. WL enhancement and histogram distribution parameters skewness, kurtosis, standard deviation (SD), and interquartile range (IQR) were calculated. WL enhancement parameters were compared to single ROI-based enhancement using receiver operating characteristic (ROC) analysis.

Results

Oncocytoma had significantly higher WL enhancement than ccRCC in nephrographic (mean, p = 0.02; median, p = 0.03) and excretory phases (mean, p = 0.03; median p < 0.01). ccRCC had significantly higher kurtosis than oncocytoma in corticomedullary (p = 0.03) and excretory phases (p < 0.01), and significantly higher SD and IQR than oncocytoma in all postcontrast phases: corticomedullary (SD, p = 0.02; IQR, p < 0.01), nephrographic (SD, p = 0.01; IQR, p = 0.03), and excretory (SD, p < 0.01; IQR, p < 0.01). When compared to single ROI-based enhancement, WL enhancement alone did not demonstrate a statistical advantage in discriminating between ccRCC and oncocytoma (area under ROC curve of 0.78 and 0.72 respectively), but when combined with histogram distribution parameters (area under ROC curve of 0.86), it did demonstrate a slight improvement.

Conclusion

Our study suggests that voxel-based WL enhancement parameters provide only a slight improvement over single ROI-based enhancement techniques in differentiating between ccRCC and renal oncocytoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33(5):534–543

    Article  PubMed  Google Scholar 

  2. Mai KT, Landry DC, Robertson SJ, et al. (2001) A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor. Pathol Res Pract 197(10):671–675

    Article  CAS  PubMed  Google Scholar 

  3. Trpkov K, Yilmaz A, Uzer D, et al. (2010) Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology 57(6):893–906

    Article  PubMed  Google Scholar 

  4. Schatz SM, Lieber MM (2003) Update on oncocytoma. Curr Urol Rep 4(1):30–35

    Article  PubMed  Google Scholar 

  5. Jasinski RW, Amendola MA, Glazer GM, Bree RL, Gikas PW (1985) Computed tomography of renal oncocytomas. Comput Radiol 9:307–314

    Article  CAS  PubMed  Google Scholar 

  6. Tikkakoski T, Paivansalo M, Alanen A, et al. (1991) Radiologic findings in renal oncocytoma. Acta Radiol 32:363–367

    Article  CAS  PubMed  Google Scholar 

  7. Quinn MJ, Hartman DS, Friedman AC, et al. (1994) Renal oncocytoma: new observations. Radiology 153:49–53

    Article  Google Scholar 

  8. Levine E, Huntrakoon M (1983) Computed tomography of renal oncocytoma. Am J Roentgenol 141(4):741–746

    Article  CAS  Google Scholar 

  9. Prasad SR, Surabhi VR, Menias CO, Raut AA, Chintapalli KN (2008) Benign renal neoplasms in adults: cross-sectional imaging findings. Am J Roentgenol 190(1):158–164

    Article  Google Scholar 

  10. Kim JI, Cho JY, Moon KC, Lee HJ, Kim SH (2009) Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma. Radiology 252(2):441–448

    Article  PubMed  Google Scholar 

  11. Schieda N, McInnes MD, Cao L (2014) Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review. Eur Radiol 24(6):1421–1429

    Article  PubMed  Google Scholar 

  12. O’Malley ME, Tran P, Hanbidge A, Rogalla P (2012) Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT? Am J Roentgenol 199(6):1312–1315

    Article  Google Scholar 

  13. McGahan JP, Lamba R, Fisher J, et al. (2011) Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas? Am J Roentgenol 197(4):W674–W679

    Article  Google Scholar 

  14. Ishigami K, Jones AR, Dahmoush L, et al. (2015) Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation. Insights Imaging 6(1):53–64

    Article  PubMed  Google Scholar 

  15. Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A (2009) Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 64(5):517–522

    Article  CAS  PubMed  Google Scholar 

  16. Bird VG, Kanagarajah P, Morillo G, et al. (2011) Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol 29(6):787–792

    Article  CAS  PubMed  Google Scholar 

  17. Pierorazio PM, Hyams ES, Tsai S, et al. (2013) Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 81(6):1265–1271

    Article  PubMed  PubMed Central  Google Scholar 

  18. Millet I, Doyon FC, Hoa D, et al. (2011) Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? Am J Roentgenol 197(4):887–896

    Article  Google Scholar 

  19. Zhang J, Lefkowitz RA, Ishill NM, et al. (2007) Solid renal cortical tumors: differentiation with CT. Radiology 244(2):494–504

    Article  PubMed  Google Scholar 

  20. Gakis G, Kramer U, Schilling D, et al. (2011) Small renal oncocytomas: differentiation with multiphase CT. Eur J Radiol 80(2):274–278

    Article  PubMed  Google Scholar 

  21. Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453

    Article  PubMed  Google Scholar 

  22. Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. Am J Roentgenol 203:W516–W524

    Article  Google Scholar 

  23. Eble J, Sauter G, Epstein J (2004) World Health Organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press

    Google Scholar 

  24. Algorithm of Clinical Management of Clinical T1 Renal Mass. 2009. https://www.auanet.org/common/pdf/education/clinical-guidance/Renal-Mass-Algorithm.pdf. Accessed 27 Oct 2015.

  25. Thompson RH, Hill JR, Babayev Y, et al. (2009) Metastatic renal cell carcinoma risk according to tumor size. J Urol 182:41–45

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 179:1227–1233

    Article  PubMed  Google Scholar 

  27. Chawla SN, Crispen PL, Hanlon AL, et al. (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175:425–431

    Article  PubMed  Google Scholar 

  28. Smaldone MC, Kutikov A, Egleston BL, et al. (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118:997–1006

    Article  PubMed  Google Scholar 

  29. Mason RJ, Abdolell M, Trottier G, et al. (2011) Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol 59:863–867

    Article  PubMed  Google Scholar 

  30. Kouba E, Smith A, McRackan D, et al. (2007) Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177:466–470

    Article  PubMed  Google Scholar 

  31. Pierorazio PM, Hyams ES, Mullins JK, Allaf ME (2012) Active surveillance for small renal masses. Nat Rev Urol 14(1–2):13–19

    Google Scholar 

  32. Volpe A, Kachura JR, Geddie WR, et al. (2007) Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178:379

    Article  PubMed  Google Scholar 

  33. Kümmerlin I, ten Kate F, Smedts F, et al. (2008) Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol 53:1219

    Article  PubMed  Google Scholar 

  34. Lebret T, Poulain JE, Molinie V, et al. (2007) Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178(4 Pt 1):1184

    Article  PubMed  Google Scholar 

  35. Schmidbauer J, Remzi M, Memarsadeghi M, et al. (2008) Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53:1003

    Article  PubMed  Google Scholar 

  36. Jeon HG, Seo SI, Jeong BC, et al. (2015) Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol S0022–5347(15):4881–4888

    Google Scholar 

  37. Chandarana H, Rosenkrantz AB, Mussi TC, et al. (2012) Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. Radiology 265:790–798

    Article  PubMed  Google Scholar 

  38. Chen F, Huhdanpaa H, Desai B, et al. (2015) Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma. Springerplus 4:66

    Article  PubMed  PubMed Central  Google Scholar 

  39. Kim JY, Kim JK, Kim N, Cho KS (2008) CT histogram analysis: differentiation of angiomyolipoma without visible fat from renal cell carcinoma at CT imaging. Radiology 246(2):472–479

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank Chen.

Ethics declarations

Funding

This project has received funding from the Whittier foundation. The project described was supported in part by the Award Number P30CA014089 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

Conflict of Interest

None of the authors have any conflict of interest to disclose.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, F., Gulati, M., Hwang, D. et al. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma. Abdom Radiol 42, 552–560 (2017). https://doi.org/10.1007/s00261-016-0891-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-016-0891-8

Keywords

Navigation